GALVmed aims to make a significant contribution towards transformational change in the small-scale livestock health landscape by developing a portfolio of high impact products and initiating a range of private sector market initiatives operating at scale in the smallholder sector.
Year in Review: GALVmed 2023This comprehensive report summarises the accomplishments and milestones that shaped the course of our journey and endeavours in 2023. From product and market development to critical partnerships and regulatory advancements, this report reflects our team’s dedication and collective efforts, contributing to the achievement of GALVmed’s mission. Read it here.
Transformational improvement in the well-being and economic progression of small-scale livestock producers.
We will contribute to the transformation of small-scale livestock producers’ lives by:
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Commercial development
Our work with our partners supports the small-scale livestock producers of the world.
Enabling Environment
An enabling environment that allows for the successful translation of research products to sustainable animal health solutions for small scale livestock producers is essential to achieving GALVmed’s mission.
2024-01-25
Livestock is a crucial source of income for small-scale livestock producers. Globally, it is estimated that around 78 per cent of the world’s poorest communities rely on agricultural work to support their livelihoods and households. However, livestock diseases represent $358.4 billion in lost production per year.
In order to understand and quantify the causal effects of ND vaccination on poultry production and livelihoods, since 2020, GALVmed has been working with Tufts University and Oxford Policy Management (OPM) to design and implement a Newcastle Disease Vaccine (NDV) intervention paired with a rigorous evaluation in rural areas of Tanzania.
There are just seven years to go until 2030. That means there are just seven years left to achieve the 17 Sustainable Development Goals (SDGs) and its 169 targets. Yet, the world was starkly reminded in July by top United Nations officials ahead of the SDG Summit that it is “tremendously off track” to reach these Goals.
Livestock is a crucial source of income for small-scale livestock producers. Globally, it is estimated that around 78 per cent of the world’s poorest communities rely on agricultural work to support their livelihoods and households. However, livestock diseases represent $358.4 billion in lost production per year.
In order to understand and quantify the causal effects of ND vaccination on poultry production and livelihoods, since 2020, GALVmed has been working with Tufts University and Oxford Policy Management (OPM) to design and implement a Newcastle Disease Vaccine (NDV) intervention paired with a rigorous evaluation in rural areas of Tanzania.
There are just seven years to go until 2030. That means there are just seven years left to achieve the 17 Sustainable Development Goals (SDGs) and its 169 targets. Yet, the world was starkly reminded in July by top United Nations officials ahead of the SDG Summit that it is “tremendously off track” to reach these Goals.
Animal welfare has the power to transform the lives of those who depend on livestock. Well-maintained animals are not only healthier and happier but also more profitable. By living longer and suffering from fewer diseases, they can save their owners considerable sums in medicines, veterinarian bills and the need to purchase or acquire new animals.
Debates about the relationship between livestock and climate change have become dominated by concerns over the carbon and methane emissions of the cattle industry. These concerns are of course valid and need to be part of climate change discussions. But they do not tell the whole story.